TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
AMGN

Amgen Inc

Healthcare · Drug Manufacturers - General

379.80$ +0.9% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement AMGN
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
22.0% 19.5% 18.1% 17.8% 17.3% 18.6% 24.2% 24.8% 24.3% 30.0% 38.5% 29.2%
78.0% 80.5% 81.9% 82.2% 82.7% 81.4% 75.8% 75.2% 75.7% 70.0% 61.5% 70.8%
21.4% 18.8% 16.7% 15.6% 15.7% 17.6% 16.5% 24.3% 16.8% 17.0% 17.8% 19.0%
23.4% 20.8% 20.1% 18.6% 19.6% 18.7% 18.8% 17.4% 17.4% 19.4% 18.3% 6.7%
47.1% 41.4% 39.3% 38.5% 39.5% 39.9% 39.8% 45.8% 39.3% 42.0% 39.8% 41.7%
30.9% 39.1% 42.6% 43.6% 43.2% 41.4% 35.9% 29.4% 36.3% 28.0% 21.7% 29.1%
5.3% 5.1% 5.5% 5.7% 5.9% 5.5% 5.0% 4.6% 5.3% 10.2% 9.4% 7.5%
27.8% 36.8% 39.9% 42.0% 40.2% 39.1% 32.0% 25.8% 27.9% 27.9% 13.8% 24.4%
2.1% 4.8% 6.3% 33.3% 4.8% 5.5% 3.4% 3.1% 3.0% 4.0% 1.6% 3.4%
25.7% 32.0% 33.6% 8.7% 35.3% 33.6% 28.6% 22.7% 24.9% 23.8% 12.2% 21.0%
43.6% 51.6% 54.5% 56.3% 54.3% 54.1% 51.1% 43.5% 46.2% 28.0% 40.0% 46.0%

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?